Pathophysiology of secondary depressions in the elderly

Journal of Geriatric Psychiatry and Neurology

Volumn 12, Issue 3, 1999, Pages 128-136

  Robinson, Robert G ^a   Chemerinski, Eran ^a   Jorge, Ricardo ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLSPIPERONE; ANTIDEPRESSANT AGENT; CARBON 11; GLUCOSE; RADIOISOTOPE; SEROTONIN RECEPTOR; SPIPERONE;

BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN METABOLISM; CINGULATE GYRUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEPRESSION; FRONTAL CORTEX; GERONTOPSYCHIATRY; GLUCOSE METABOLISM; HUMAN; HUNTINGTON CHOREA; HYPOTHESIS; NEUROCHEMISTRY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; STROKE; TEMPORAL CORTEX; TEMPORAL LOBE; THALAMUS;

EID: 0033388626     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198879901200306     Document Type: Review

References (80)

1. Bear DM. Hemispheric specialization and the neurology of emotion. Arch Neurol 1983; 40:195-202.
2. Mayeux R, Stern Y, Sano M. The relationship of serotonin into depression in Parkinson's disease. Mov Disord 1988; 3:237-244.
3. Cantello R, Aguaggia M, Gilli M, et al. Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. J Neurol Neurosurg Psychiatry 1989; 52:724-731.
4. McHugh PR. The basal ganglia: the region, the integration of its systems and implications for psychiatry and neurology. In: Franks AJ, ed. Function and dysfunction of the basal ganglia. Manchester: Manchester University Press, 1990:259-269.
5. Caine ED, Shoulson I. Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983; 140:728-733.
6. Gothan AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986; 49:381-389.
7. Goodstein RK, Ferrel RB. Multiple sclerosis presenting as depressive illness. Dis Nerv System 1977; 38:127-131.
8. Nemeroff CB. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1989; 50(Suppl):13-22.
9. Omdal R, Mellgren SI, Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosis. Scand J Rheumatol 1988; 17:113-117.
10. Cummings JL, Victoroff JI. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1990; 2:140-158.
11. Zubenko GS, Moosy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47:209-214.
12. Honer WG, Hurwitz T, Li DK, et al. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987; 44:187-190.
13. Starkstein SE, Robinson RG, Preziosi TJ. Depression in Parkinson's disease. J Nerv Ment Dis 1990; 178:27-31.
14. Folstein SE, Abbott MH, Chase GA, et al. The association of affective disorder with Huntington's disease in a case series and in families. Psychol Med 1983; 13:537-542.
15. Peyser CE, Folstein SE. Huntington's disease as a model for mood disorders: clues from neuropathology and neurochemistry. Mol Chem Neuropathol 1990; 12:99-119.
16. Albert ML, Feldman RG, Willis AL. The subcortical dementia of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37:121-130.
17. Dening TR, Berrios GE. Wilson's disease: psychiatric symptoms in 195 patients. Arch Gen Psychiatry 1989; 46:1126-1134.
18. Lishman WA. Brain damage in relation to psychiatric disability after head injury. Br J Psychiatry 1968; 114:373-410.
19. Grafman J, Vance SC, Swingartner H. The effects of lateralized frontal lesions on mood regulation. Brain 1986; 109:1127-1148.
20. Jorge RE, Robinson RG, Arndt SV, et al. Comparison between acute and delayed onset depression following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993; 5:43-49.
21. Jorge RE, Robinson RG, Starkstein SE, Arndt SV. Depression and anxiety following traumatic brain injury. J Neuropsychiatry Clin Neurosci 1993; 5:43-49.
22. Eslinger PJ, Damasio AR. Severe bilateral disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology 1985; 35:1731-1741.
23. Robinson RG. The clinical neuropsychiatry of stroke. Cambridge, UK: Cambridge University Press, 1998.
24. Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy: laterality of focus and symptoms. Arch Neurol 1990; 47:284-288.
25. Bear D, Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977; 34:454-467.
26. Robertson MM, Trimble MR, Townsend HRA. Phenomenology of depression in epilepsy. Epilepsia 1987; 28:364-368.
27. Phelps ME, Maziotta JC, Huang SC. Studies of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 1982; 2:113-162.
28. 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 1980; 4:727-736.
29. Phelps ME, Huang SC, Hoffman EH, et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with [18-F]2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6:371-388.
30. Yen CK, Budinger TF. Evaluation of blood-brain barrier permeability changes in rhesus monkeys and humans using 82Rb and positron emission tomography. J Comput Assist Tomogr 1981; 5:792-799.
31. Comar D, Cartron JC, Maziere M, Marazano C. Labelling and metabolism of methionine-methyl-11C. Eur J Nucl Med 1976; 1:11-14.
32. Gjedde A, Wong DF. Modeling neuroreceptor binding of radioligands in vivo. In: Frost JJ, Wagner HN, eds. Quantitative imaging: neuroreceptors, neurotransmitters and enzymes. New York: Raven Press, 1990:51-79.
33. Huang SC, Bario JR, Phelps MD. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J Cereb Blood Flow Metab 1986; 6:515-521.
34. Baxter LR, Phelps ME, Mazziotta JC. Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42:441-447.
35. Buchsbaum MS, Wu J, DeLisi LE, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18-F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10:137-152.
36. Baxter LR Jr, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250.
37. Drevets WC, Videen TO, Price JL, et al. A functional anatomical study of unipolar depression. J Neurosci 1992; 12:3628-3641.
38. Martinot JL, Hardy P, Feline A, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147:1313-1317.
39. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8:1056-1061.
40. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827.
41. Mayberg HS, Starkstein SE. Limbic cortex hypometabolism in depression: similarities among patients with Huntington's disease, Parkinson's disease and basal ganglia strokes. J Cereb Blood Flow Metab 1991; 11:8-21.
42. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990; 85:119-146.
43. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994; 64:358-370.
44. Burvill PW, Johnson GA, Jamrozik KD, et al. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry 1995; 166:320-327.
45. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24:976-982.
46. Robinson RG, Schultz SK, Paradiso S. Treatment of poststroke psychiatric disorders. In: Nelson JC, ed. Geriatric psychopharmacology. New York: Marcel Dekker, 1998:161-185.
47. Castillo CS, Schultz SK, Robinson RG. Clinical correlates of early-onset and late-onset poststroke generalized anxiety. Am J Psychiatry 1995; 152:1174-1179.
48. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol 1981; 9:447-453.
49. Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients: importance of location of lesion. Brain 1984; 107:81-93.
50. Starkstein SE, Pearlson GD, Boston J, Robinson RG. Mania after brain injury: a controlled study of causative factors. Arch Neurol 1987; 44:1069-1073.
51. Morris PLP, Robinson RG, Carvalho ML, et al. Lesion characteristics and depressed mood in the stroke data bank study. J Neuropsychiatry Clin Neurosci 1996; 8:153-159.
52. Herrmann M, Bartles C, Wallesch C-W. Depression in acute and chronic aphasia: symptoms, pathoanatomical-clinical correlations and functional implications. J Neurol Neurosurg Psychiatry 1993; 56:672-678.
53. House A, Dennis M, Warlow C, et al. Mood disorders after stroke and their relation to lesion location. A CT scan study. Brain 1990; 113:1113-1130.
54. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br J Psychiatry 1989; 154:195-200.
55. Sinyor D, Cooper E, Sartorius N. Relationship to functional impairment coping strategies and rehabilitation outcome. Stroke 1986; 17:1102-1107.
56. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999; 45:187-192.
57. Bryer JB, Starkstein SE, Votypka V, et al. Reduction of CSF monoamine metabolites in post-stroke depression. J Neuropsychiatry Clin Neurosci 1992; 55:377-382.
58. Baron JC. Depression of energy metabolism in distant brain structures: studies with positron emission tomography in stroke patients. Semin Neurol 1989; 9:281-285.
59. Mayberg HS. Neuroimaging studies of depression in neurologic disease. In: Starkstein SE, Robinson RG, eds. Depression in neurologic disease. Baltimore: Johns Hopkins Press, 1993:186-216.
60. 2-serotonin receptors after stroke: lateralized changes and relationship to depression. Am J Psychiatry 1988; 145:937-943.
61. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28:57-64.
62. Robinson RG. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science 1979; 105:707-710.
63. Torack RM, Morris JC. The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 1988; 45:211-218.
64. Bejjani B-P, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999; 340:1476-1479.
65. Mayeux R, Stern Y, William JBW. Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 1986; 143:756-759.
66. Kuhl DE, Metter EJ, Riege WH. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F] fluorodeoxyglucose method. Ann Neurol 1984; 15:419-424.
67. Martin WR, Beckman JH, Calne DB, et al. Cerebral glucose metabolism in Parkinson's disease. Can J Neurol Sci 1984; 11(Suppl 1):169-173.
68. Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985; 35:1127-1134.
69. 3H-spiperone binding following focal frontal cortex lesions in the rat. Brain Res 1990; 516:127-131.
70. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. TINS 1989; 12:366-375.
71. Albin RL, Young AB, Penney JB, et al. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 1990; 322:1293-1298.
72. Beal MF, Martin JB. Neuropeptides in neurological disease. Ann Neurol 1986; 20:547-565.
73. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of Huntington in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 1997; 277:1990-1993.
74. Starkstein SE, Folstein SE, Brandt J, et al. Brain atrophy in Huntington's disease. A CT-scan study. Neuroradiology 1989; 31:156-159.
75. Berent S, Giordani B, Lehtinen S, et al. Positron emission tomography scan investigation of Huntington's disease: cerebral metabolic correlations of cognitive function. Ann Neurol 1988; 23:541-546.
76. Kuhl DE, Phelps ME, Markham CH, et al. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol 1982; 12:425-434.
77. Mayberg HS, Starkstein SE, Peyser CE, et al. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992; 42:1791-1797.
78. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exper Neurol 1985; 44:559-577.
79. Sotrel A, Myers RH. Morphometric analysis of prefrontal cortex in Huntington's disease. Neurology 1991; 41:1117-1123.
80. Nauta WJH. The problem of the frontal lobe: a reinterpretation. J Psychol Res 1971; 8:167-187.